Literature DB >> 2421289

Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.

M B Bacaner, J R Clay, A Shrier, R M Brochu.   

Abstract

The suppression of ventricular fibrillation by antidysrhythmic drugs is well correlated with their ability to block potassium channels in nerve and cardiac membranes. Blockade of potassium channels reduces electrical inhomogeneities in action potential and conduction parameters that lead to ventricular fibrillation. These actions tend to effectively decrease the electrical size of the heart, which suggests a mechanism for antifibrillatory drug action. The receptor sites for antifibrillatory drug action (IK blockade) appear to be on the outside of the cardiac membrane whereas receptors for antiarrhythmic drug action (INa blockade) appear to be on the inside of the cardiac membrane.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421289      PMCID: PMC323264          DOI: 10.1073/pnas.83.7.2223

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  A quantitative description of membrane current and its application to conduction and excitation in nerve.

Authors:  A L HODGKIN; A F HUXLEY
Journal:  J Physiol       Date:  1952-08       Impact factor: 5.182

2.  Quantitiative comparison of bretylium with other antifibrillatory drugs.

Authors:  M B Bacaner
Journal:  Am J Cardiol       Date:  1968-04       Impact factor: 2.778

3.  Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate.

Authors:  M B Bacaner
Journal:  Am J Cardiol       Date:  1968-04       Impact factor: 2.778

4.  Normal and abnormal excitation of cardiac muscle fibers, especially fibrillation.

Authors:  T Sano
Journal:  Jpn Circ J       Date:  1967-11

Review 5.  Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refuted.

Authors:  M Bacaner
Journal:  Int J Cardiol       Date:  1983-09       Impact factor: 4.164

6.  Bretylium tosylate for suppression of induced ventricular fibrillation.

Authors:  M Bacaner
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

7.  The coronary care unit. New perspectives and directions.

Authors:  B Lown; A M Fakhro; W B Hood; G W Thorn
Journal:  JAMA       Date:  1967-01-16       Impact factor: 56.272

8.  A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

9.  The selective inhibition of delayed potassium currents in nerve by tetraethylammonium ion.

Authors:  B Hille
Journal:  J Gen Physiol       Date:  1967-05       Impact factor: 4.086

10.  ANOMALOUS RECTIFICATION IN THE SQUID GIANT AXON INJECTED WITH TETRAETHYLAMMONIUM CHLORIDE.

Authors:  C M ARMSTRONG; L BINSTOCK
Journal:  J Gen Physiol       Date:  1965-05       Impact factor: 4.086

View more
  11 in total

Review 1.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

2.  Selective inhibition of K(+)-stimulation of Na,K-ATPase by bretylium.

Authors:  P E Tiku; P T Nowell
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  A new kalium channel blocker of Chinese medicinal origin--benzyltetrahydropalmatine hydrochloride.

Authors:  W X Yao; G J Xia; J S Zhang; W Z Zeng; S D Zhang; M X Jiang
Journal:  J Tongji Med Univ       Date:  1990

4.  9-Amino-1,2,3,4-tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels.

Authors:  W Osterrieder
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

5.  Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle.

Authors:  G Scholtysik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

6.  Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.

Authors:  G N Beatch; S Abraham; B A MacLeod; N R Yoshida; M J Walker
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

7.  Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.

Authors:  A Bril; L Landais; B Gout
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

Review 8.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.

Authors:  H Satoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

10.  Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents.

Authors:  J L Berry; R C Small; R W Foster
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.